Key clinical point: The exact cause of EVALI remains unknown.
Major finding: THC-containing product use was reported by 92% of patients during the 3 months preceding illness.
Study details: Interview of 53/83 EVALI patients in Utah Aug.-Oct. 2019.
Disclosures: The authors reported that they had no conflicts.
Lewis N et al. MMWR Morb Mortal Wkly Rep. Early Release. Oct. 22, 2019. 68:1-5.